SecBot SecBot
8-K ·Filed Apr 24, 2026

AMS

AMERICAN SHARED HOSPITAL SERVICES
BEARISH
Impact 6/10
Horizonweeks Processed6mo ago SEC0001437749-26-013331
8-K context-dependent: Items 5.02
Actionable Insight ▼ Bearish

Monitor for signs of operational continuity or strategic shifts under interim leadership. The lack of a permanent CEO and compensation increase for the interim appointee may signal internal challenges at this $9M market cap company. Watch upcoming 10-Q for guidance updates.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
AMS ▲ +8.33% at T+60d
SHORT call ✗ call lost -8.33% · α vs SPY -3.56% · entry $1.32 → $1.43
Entry = T+0 close
Apr 24, 2026
via day close
T+1d
+0.76%
call -0.76% · α -1.24%
$1.33
settled 6mo ago
T+5d
+39.39%
call -39.39% · α -38.99%
$1.84
settled 6mo ago
T+20d
+2.27%
call -2.27% · α +2.68%
$1.35
settled 5mo ago
T+60d
+8.33%
call -8.33% · α -3.56%
$1.43
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

American Shared Hospital Services CEO Gary Delanois resigned for personal reasons, effective April 24, 2026. President Craig K. Tagawa was appointed interim CEO effective April 27, 2026, and received a salary increase from $265,000 to $325,000 and a higher target bonus. This leadership transition introduces near-term uncertainty for the micro-cap medical services firm.

Key Facts

  • CEO Gary Delanois resigned effective April 24, 2026, for personal reasons
  • Craig K. Tagawa, President since 2020, appointed interim CEO effective April 27, 2026
  • Tagawa's base salary increased from $265,000 to $325,000 with target bonus rising from 40% to 50% of base
  • No permanent CEO replacement named; Tagawa assumes role on interim basis

Financial Impact

Increased annual executive compensation by $60,000 in base salary and up to $32,500 in target bonus for interim CEO

executive compensationoperating expenses

Risk Factors

  • Leadership instability with interim CEO appointment
  • Potential strategic uncertainty during transition period
  • Increased compensation costs with no guaranteed performance improvement

Market Snapshot

Exchange
NYSE
Sector
Services-Medical Laboratories

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001437749-26-013331
Document: 0001437749-26-013331-index-headers.html0001437749-26-013331
Document: 0001437749-26-013331-index.html0001437749-26-013331
Document: 0001437749-26-013331.txt0001437749-26-013331
11 reports for AMS
Performance horizon
100% Hit rate @ T+20 4 of 4 directional calls Went positive at some point 4 of 4 best @ T+60▲ +17.65%Jul 28, 2026
Filters
Rows
Reports for AMS — sortable, filterable
TypeNow
Aug 13, 2026
10w ago
8-K
MIXED ★ 6/10
$1.60 $1.47▼ −7.84%▼ −6.10%$1.28 (−20.00%)
Jul 28, 2026
12w ago
8-K
BEARISH ★ 8/10
$1.53 $1.51▲ +1.31%▲ +6.33%$1.28 (+16.34%)
Jun 30, 2026
17w ago
8-K
NEUTRAL ★ 2/10
$1.58 $1.54▼ −2.53%▼ −1.50%$1.28 (−18.99%)
May 14, 2026
23w ago
8-K
BEARISH ★ 6/10
$1.58 $1.42▲ +10.13%▲ +9.27%$1.28 (+18.99%)
May 14, 2026
23w ago
Press Release
MIXED ★ 6/10
$1.58 $1.42▼ −10.13%▼ −9.27%$1.28 (−18.99%)
May 7, 2026
24w ago
DEFA14A
NEUTRAL ★ 2/10
$2.01 $1.37▼ −31.84%▼ −34.98%$1.28 (−36.32%)
Apr 30, 2026
25w ago
DEFA14A
NEUTRAL ★ 3/10
$1.45 $1.64▲ +13.10%▲ +8.14%$1.28 (−11.72%)
Apr 24, 2026
26w ago
8-K
BEARISH ★ 6/10
$1.32 $1.35▼ −2.27%▲ +2.68%$1.28 (+3.03%)
Mar 31, 2026
30w ago
8-K
BEARISH ★ 8/10
$1.45 $1.34▲ +7.59%▲ +17.01%$1.28 (+11.72%)
Mar 31, 2026
30w ago
Press Release
BEARISH ★ 7/10
$1.45 $1.34▲ +7.59%▲ +17.01%$1.28 (+11.72%)
Showing 10 of 11

US Market Status

Market Closed — Opens Wed (17h 23m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 24, 2026